Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지

Folate during reproduction: the Canadian experience with folic acid fortification

  • Lindzon, Gillian (Department of Nutritional Sciences, University of Toronto) ;
  • O'Connor, Deborah L. (Physiology and Experimental Medicine Program and Department of Clinical Dietetics, The Hospital for Sick Children)
  • Published : 2007.09.20
Download PDF
⟨ Previous Next ⟩

Abstract

Folate has received international attention regarding its role in the risk-reduction of birth defects, specifically neural tube defects (NTDs). In 1998 health officials in Canada, like the United States, mandated the addition of folic acid to white flour and select grain product's to increase the folate intake of reproductive-aged women. Subsequent to this initiative there has been an increase in blood folate concentrations in Canada and a 50% reduction in NTDs. Many countries, including Korea, have not mandated folic acid fortification of their food supply. Reasons vary but often include concern over the masking of vitamin $B_{12}$ deficiency, a belief that folate intakes among womenare adequate, low priority relative to other domestic issues, and the philosophy that individuals have the right not to consume supplemental folic acid if they so choose. Prior to folic acid fortification of the food supply in Canada, the folate intakes of women were low, and their blood folate concentrations while not sufficiently low to produce overt signs of folate deficiency (eg. anemia) were inconsistent with a level known to reduce the risk of an NTD-affected pregnancy. The purpose of this article is to describe the role of folate during the periconceptional period, pregnancy, and during lactation. The rationale for, and history of recommending folic acid-containing supplements during the periconceptional period and pregnancy is described as is folic acid fortification of the food supply. The impact of folic acid fortification in Canada is discussed, and unresolved issues associated with this policy described. While the incidence of NTDs in Canada pre-folic acid fortification were seemingly higherthan that of Korea today, blood folate levels of Korean women are strikingly similar. We will briefly explore these parallels in an attempt to understand whether folic acid fortification of the food supply in Korean might be worth consideration.

Keywords

References

  1. American Academy of Pediatrics (2005). Breastfeeding and the use of human milk. Pediatrics 115:496-506 https://doi.org/10.1542/peds.2004-2491
  2. Badovinac RL, Werler MM, Williams PL, Kelsey KT & Hayes C (2007). Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 79:8-15 https://doi.org/10.1002/bdra.20315
  3. Bailey LB (2003). Folate, methyl-related nutrients, alcohol, and the MTHFR $677C{\rightarrow}T$ polymorphism affect cancer risk: intake recommendations. J Nutr 133:3748S-3753S https://doi.org/10.1093/jn/133.11.3748S
  4. Bailey LB, Rampersaud GC & Kauwell GP (2003). Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer; evolving science. J Nutr 133:1961-1968S https://doi.org/10.1093/jn/133.6.1961S
  5. Baumslag N, Edelstein T & Metz J (1970). Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J 1:16-17 https://doi.org/10.1136/bmj.1.5687.16
  6. Blackburn S & Loper DL (1992). The hematologic and hemostatic systems. In Blackburn S (ed), Maternal, fetal, and neonatal physiology: a clinical perspective, p.159-200. Saunders Company, Philadelphia. USA
  7. Blom HJ (1998). Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia. Eur J Pediatr 157:S131-S134 https://doi.org/10.1007/PL00014297
  8. Blom HJ, Shaw GM, den Heijer M & Finnell RH (2006). Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7:724-731 https://doi.org/10.1038/nrn1986
  9. Botto LD, Khoury MJ, Mulinare J & Erickson JD (1996). Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98:911-917
  10. Chanarin I (1969). The megaloblastic anaemias. Blackwell, London. UK
  11. Chang NS, Kang MH, Paik HY, Kim IH, Cho YW, Park SC & Shin YW (1993). Serum folate and iron levels of pregnant, lactating adn non-pregnant, non-lactating women. The Korean Journal of Nutrition 26:67-75
  12. Chen LT & Rivera MA (2004). The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 62:S40-S43 https://doi.org/10.1301/nr.2004.jun.S40-S43
  13. Choi JH, Kim HA & Lim HS (2006). MTHFR polymorphism and folate status of Korean women of childbearing age. Nutritional Sciences 9:35-41
  14. Choumenkovitch SF, Jacques PF, Nadeau MR, WIlson PW, Rosenberg IH & Selhub J (2001). Folic acid fortification increases red blood cell foalte concentrations in the Framingham study. J Nutr 131:3277-3280
  15. Choumenkovitch SF, Selhub J, WIlson PW, Rader JI, Rosenberg IH & Jacques PF (2002). Folic acid intake from fortification in United States exceeds predictions. J Nutr 132:2792-2798
  16. Czeizel AE (1993). Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 306:1645-1648 https://doi.org/10.1136/bmj.306.6893.1645
  17. Czeizel AE (1996). Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183 https://doi.org/10.1002/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L
  18. Czeizel AE, Timar L & Sarkozi A (1999). Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 104:e66 https://doi.org/10.1542/peds.104.6.e66
  19. Daly LE, Kirke PN, Molloy A, Weir DG & Scott JM (1995). Folate levels and neural tube defects. Implications for prevention. JAMA 274:1698-702 https://doi.org/10.1001/jama.274.21.1698
  20. Davis SR, Quinlivan EP, Shelnutt KP, Maneval DR, Ghandour H, Capdevila A, Coats BS, Wagner C, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW & Gregory JF 3rd (2005). The methylenetetrahydrofolate reductase $677C{\rightarrow}T$ polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J Nutr 135:1040-1044 https://doi.org/10.1093/jn/135.5.1040
  21. De Wals P, Rusen ID, Lee NS, Morin P & Niyonsenga T (2003). Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol 67:919-923 https://doi.org/10.1002/bdra.10124
  22. Dietrich M, Brown CJ & Block G (2005). The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult nonsupplement users in the United States. J Am Coll Nutr 24:266-274 https://doi.org/10.1080/07315724.2005.10719474
  23. Eichholzer M, Tonz O & Zimmermann R (2006). Folic acid: a public-health challenge. Lancet 367:1352-1361 https://doi.org/10.1016/S0140-6736(06)68582-6
  24. Eskes TK (2006). Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature. Eur J Obstet Gynecol Reprod Biol 124:130-133 https://doi.org/10.1016/j.ejogrb.2005.07.028
  25. French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, Greenberg M & Koren G (2003). Folic acid food fortification is associated with a decline in neuroblatoma. Clin Pharmacol Ther 74:288-294 https://doi.org/10.1016/S0009-9236(03)00200-5
  26. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R & Selhub J (2002). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99: 5606-5611
  27. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA & van den Heuvel LP et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113 https://doi.org/10.1038/ng0595-111
  28. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG & Rozen R (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200 https://doi.org/10.1038/ng0694-195
  29. Green TJ, Allen OB & O'Connor DL (1998a). A three-day weighed food record and a semiquantitative food-frequency questionnaire are valid measures for assessing the folate and vitamin B-12 intakes of women aged 16 to 19 years. J Nutr 128:1665-1671
  30. Green TJ, Houghton LA, Donovan U, Gibson RS & O'Connor DL (1998b). Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diet Assoc 98:49-55 https://doi.org/10.1016/S0002-8223(98)00014-5
  31. Gucciardi E, Pietrusiak MA, Reynolds DL & Rouleau J (2002). Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 167:237-240
  32. Han YH, Yon M & Hyun TH (2005). Folate intake estimated with an updated database and its association to blood folate and homocysteine in Korean college students. Eur J Clin Nutr 59: 246-254 https://doi.org/10.1038/sj.ejcn.1602065
  33. Health Canada (2004). Exclusive breastfeeding duration. http://www.hc-sc.gc.ca/fn-an/nutrition/child-enfant/infant-nourisson/excl_bf_dur-dur_am_excl_e.html. Accessed on 2004
  34. Health Canada (2007). Eating Well with Canada's Food Guide: A Resource for Educators and Communicators. http:// www.healthcanada.gc.ca/foodguide. Accessed on 2007
  35. Hertrampf E & Cortes F (2004). Folic acid fortification of wheat flour: Chile. Nutr Rev 62:S44-8; discussion S49 https://doi.org/10.1301/nr.2004.jun.S44-S48
  36. Hirsch S, de la Maza P, Barrera G, Gattas V, Petermann M & Bunout D (2002). The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people. J Nutr 132:289-291
  37. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD & Wong LY (2001). Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986 https://doi.org/10.1001/jama.285.23.2981
  38. Houghton LA, Sherwood KL, Pawlosky R, Ito S & O'Connor DL (2006). [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr 83:842-850 https://doi.org/10.1093/ajcn/83.4.842
  39. House JD, March SB, Ratnam MS, Crowley M & Friel JK (2006). Improvements in the status of folate and cobalamin in pregnant Newfoundland women are consistent with observed reductions in the incidence of neural tube defects. Can J Public Health 97:132-135
  40. Institute of Medicine (1998). Food and Nutrition Board. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin $B_6$, folate, vitamin $B_{12}$, pantothenic acid, biotin, and choline. National Academy Press, Washington, DC. USA
  41. Iyengar L & Rajalakshmi K (1975). Effect of folic acid supplement on birth weights of infants. Am J Obstet Gynecol 122:332-336 https://doi.org/10.1016/0002-9378(75)90179-9
  42. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J & Rozen R (1996). Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9 https://doi.org/10.1161/01.CIR.93.1.7
  43. Jacques PF, Selhub J, Bostom AG, Wilson, PW & Rosenberg IH (1999). The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New Engl J Med 340:1449-1454 https://doi.org/10.1056/NEJM199905133401901
  44. Jugessur A, Wilcox AJ, Lie RT, Murray JC, Taylor JA, Ulvik A, Drevon CA, Vindenes HA & Abyholm FE (2003). Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol 157:1083-1091 https://doi.org/10.1093/aje/kwg097
  45. Jung SC, Kim SS, Yoon KS & Lee JS (1999). Prevalence of congenital malformations and genetic diseases in Korea. J Hum Genet 44:30-34 https://doi.org/10.1007/s100380050102
  46. Kim KN, Kim YJ & Chang N (2004). Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. Eur J Clin Nutr 58:10-16 https://doi.org/10.1038/sj.ejcn.1601729
  47. Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66-88 https://doi.org/10.1016/S0955-2863(98)00074-6
  48. Kim YI (2000). Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 95:205-209
  49. Kim YI (2003). Role of folate in colon cnacer development and progression. J Nutr 133:3731-3795
  50. Kim YI (2004a). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13:511-519
  51. Kim YI (2004b). Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80:1123-1128 https://doi.org/10.1093/ajcn/80.5.1123
  52. Kleinman RE (2004). Pediatric Nutrition Handbook. Fifth Edition, Vol. 3, Breastfeeding, p.55-86. American Academy of Pediatrics. USA
  53. Lee JI, Lee JA & Lim HS (2005). Effect of time of initiation and dose of prenatal iron and folic acid supplementation on iron and folate nutriture of Korean women during pregnancy. Am J Clin Nutr 82:843-849 https://doi.org/10.1093/ajcn/82.4.843
  54. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG & Weiss NS (1995). Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:212-218 https://doi.org/10.1097/00001648-199505000-00004
  55. Lim HS, Jin HO & Lee JA (2000). Dietary intakes and status of folate in Korean women of child-bearing potential. The Korean Journal of Nutrition 33:296-303
  56. Lim HS, Lee JI &Lee JA (1999). Folate status of Korean pregnant women and their pregnancy outcomes - a cross-section study. The Korean Journal of Nutrition 32:592-597
  57. Lindsey LLM, Carter H, Pruc C & Mulinare J (2005). Use of dietary supplements containing folic acid among women of childbearing age-United States 2005. MMWR Weekly 54:955-958
  58. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, Crowley M, Lam A, Prabhakaran V & McCourt C (2004). A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth 4:20 https://doi.org/10.1186/1471-2393-4-20
  59. Lucock M (2000). Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71: 121-38 https://doi.org/10.1006/mgme.2000.3027
  60. Lumley J, Watson L, Watson M & Bower C (2001). Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev CD001056
  61. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH & Rozen R (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57:1098-1102
  62. Mackey AD & Picciano MF (1999). Maternal folate status during extended lactation and the effect of supplemental folic acid. Am J Clin Nutr 69:285-292 https://doi.org/10.1093/ajcn/69.2.285
  63. Mathews F, Yudkin P & Neil A (1998). Folates in the periconceptional period: are women getting enough? Br J Obstet Gynaecol 105:954-959 https://doi.org/10.1111/j.1471-0528.1998.tb10257.x
  64. Mills JL, Kirke PN, Molloy AM, Burke H, Conley MR, Lee YJ, Mayne PD, Weir DG & Scott JM (1999). Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 86:71-74 https://doi.org/10.1002/(SICI)1096-8628(19990903)86:1<71::AID-AJMG14>3.0.CO;2-Y
  65. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D & Tremblay C (2002). Pregnancy planning and folic acid supplement use: results from a survey in Quebec. Prev Med 35:143-149 https://doi.org/10.1006/pmed.2002.1041
  66. MRC Vitamin Study Research Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137 https://doi.org/10.1016/0140-6736(91)90133-A
  67. Nakazawa Y, Chiba K, Imatoh N, Kotorii T & Sakamoto T (1983). Ishizaki T: Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers. Drug Alcohol Depend 11:201-207 https://doi.org/10.1016/0376-8716(83)90079-0
  68. O'Connor DL (1994). The folate status of Canadian women. In Koren G (ed), Folic acid for the prevention of neural tube defects. The Motherisk Program, Toronto. Canada
  69. O'Connor DL, Green T & Picciano MF (1997). Maternal folate status and lactation. J Mammary Gland Biol Neoplasia 2:279-289 https://doi.org/10.1023/A:1026388522182
  70. O'Connor DL, Tamura T & Picciano MF (1991). Pteroylpolyglutamates in human milk. Am J Clin Nutr 53:930-934 https://doi.org/10.1093/ajcn/53.4.930
  71. Oi S (2003). Current status of prenatal management of fetal spina bifida in the world: worldwide cooperative survey on the medicoethical issue. Childs Nerv Syst 19:596-599 https://doi.org/10.1007/s00381-003-0778-1
  72. Ortega RM, Lopez-Sobaler AM, Gonzalez-Gross MM, Redondo RM, Marzana I, Zamora MJ & Andres P (1994). Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am Coll Nutr 13:68-72 https://doi.org/10.1080/07315724.1994.10718374
  73. Parle-McDermott A, Mills JL, Molloy AM, Carroll N, Kirke PN, Cox C, Conley MR, Pangilinan FJ, Brody LC & Scott JM (2006). The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 88:290-294 https://doi.org/10.1016/j.ymgme.2006.02.011
  74. Persad VL, Van den Hof MC, Dube JM & Zimmer P (2002). Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 167:241-245
  75. Pfeiffer CM, Rogers LM, Bailey LB & Gregory JF 3rd (1997). Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am J Clin Nutr 66:1388-1397 https://doi.org/10.1093/ajcn/66.6.1388
  76. Picciano M, Green T & O'Connor D (1994). The folate status of women and health. Nutr Today 29:20-29 https://doi.org/10.1097/00017285-199412000-00005
  77. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW & Krumdieck CL (1994). Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 60:559-566 https://doi.org/10.1093/ajcn/60.4.559
  78. Quinlivan EP & Gregory JF 3rd (2003a). Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 77: 221-225 https://doi.org/10.1093/ajcn/77.1.221
  79. Quinlivan EP & Gregory JF 3rd (2003b). The impact of food fortification on folic acid intake in Canada. Can J Public Health 94:154
  80. Qvist I, Abdulla M, Jagerstad M & Svensson S (1986). Iron, zinc and folate status during pregnancy and two months after delivery. Acta Obstet Gynecol Scand 65:15-22
  81. Ray JG (1998). Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158:2101-2106 https://doi.org/10.1001/archinte.158.19.2101
  82. Ray JG (2004). Folic acid food fortification in Canada. Nutr Rev 62:S35-S39 https://doi.org/10.1301/nr.2004.jun.S35-S39
  83. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR & Cole DE (2002a). Association of neural tube defects and folic acid food fortification in Canada. Lancet 360:2047-2048 https://doi.org/10.1016/S0140-6736(02)11994-5
  84. Ray JG, Meier C, Vermeulen MJ, Wyatt PR & Cole DE (2003). Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 143:805-807 https://doi.org/10.1067/S0022-3476(03)00495-5
  85. Ray JG, Vermeulen MJ, Boss SC & Cole DE (2002b). Declining rate of folate insufficiency among adults following increased folic acid food fortification in Canada. Can J Public Health 93:249-253
  86. Ray JG, Vermeulen MJ, Boss SC & Cole DE (2002c). Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology 13:238-240
  87. Regulatory impact analysis statement (1998). SOR/98-550, Canada Gazette Part II, 3029-3033
  88. Scholl TO, Hediger ML, Schall JI, Khoo CS & Fischer RL (1996). Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 63:520-525 https://doi.org/10.1093/ajcn/63.4.520
  89. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW & Wolf PA (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483 https://doi.org/10.1056/NEJMoa011613
  90. Senti FR & Pilch SM (1985). Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II). J Nutr 115:1398-1402 https://doi.org/10.1093/jn/115.11.1398
  91. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM & Lammer EJ (1995). Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59:536-545 https://doi.org/10.1002/ajmg.1320590428
  92. Shaw GM, Rozen R, Finnell RH, Todoroff K & Lammer EJ (1998). Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet 80:196-198 https://doi.org/10.1002/(SICI)1096-8628(19981116)80:3<196::AID-AJMG2>3.0.CO;2-V
  93. Sherwood KL, Houghton LA, Tarasuk V & O'Connor DL (2006). One-third of pregnant and lactating women may not be meeting their folate requirements from diet alone based on mandated levels of folic acid fortification. J Nutr 136:2820-2826
  94. Smith DE, Kok RM, Teerlink T, Jakobs C & Smulders YM (2006). Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 44:450-459 https://doi.org/10.1515/CCLM.2006.085
  95. Smithells RW, Sheppard S & Schorah CJ (1976). Vitamin deficiencies and neural tube defects. Arch Dis Child 51:944-950 https://doi.org/10.1136/adc.51.12.944
  96. Smulders YM, Smith DE, Kok RM, Teerlink T, Gellekink H, Vaes WH, Stehouwer CD & Jakobs C (2007). Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status. J Nutr Biochem Apr 4;[Epub ahead of print]
  97. Sohn KJ, Croxford R, Yates Z, Lucock M & Kim YI (2004). Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96:134-144 https://doi.org/10.1093/jnci/djh015
  98. Sutterlin MW, Bussen SS, Rieger L, Dietl J & Steck T (2003). Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. Eur J Obstet Gynecol Reprod Biol 107:57-61 https://doi.org/10.1016/S0301-2115(02)00371-8
  99. Tamura T & Picciano MF (2006). Folate and human reproduction. Am J Clin Nutr 83:993-1016 https://doi.org/10.1093/ajcn/83.5.993
  100. Tolarova M (1982). Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 2:217
  101. Ueland PM, Hustad S, Schneede J, Refsum H & Vollset SE (2001). Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195-201 https://doi.org/10.1016/S0165-6147(00)01675-8
  102. van Rooij IA, Vermeij-Keers C, Kluijtmans LA, Ocke MC, Zielhuis GA, Goorhuis-Brouwer SM, van der Biezen JJ, Kuijpers-Jagtman AM & Steegers-Theunissen RP (2003). Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 157:583-591 https://doi.org/10.1093/aje/kwg005
  103. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL & Ueland PM (2000). Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 71:962-968 https://doi.org/10.1093/ajcn/71.4.962
  104. Wilcox AJ (2001). On the importance-and the unimportance-of birthweight. Int J Epidemiol 30:1233-1241 https://doi.org/10.1093/ije/30.6.1233
  105. Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, Vindenes H, Vollset SE & Drevon CA (2007). Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 334:464 https://doi.org/10.1136/bmj.39079.618287.0B
  106. Witter FR, Blake DA, Baumgardner R, Mellits ED & Niebyl JR (1982). Folate, carotene, and smoking. Am J Obstet Gynecol 144:857 https://doi.org/10.1016/0002-9378(82)90369-6
  107. World Health Organization (2001). Global Strategies for Infant and Young Child Feeding. Resolution Passes at: Fifty-fourth World Health Assembly; May 9. http//www.who.int/ child-adolescenthealth/NUTRITION/global_strategy.htm. Accessed on 2001
  108. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, Steegers-Theunissen RP & Eskes TK (1993). Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 60:820-825 https://doi.org/10.1016/S0015-0282(16)56282-7
  109. Yon M & Hyun TH (2003). Folate content of foods commonly consumed in Korea measured after trienzyme extraction. Nutr Res 23:735-746